
About Pharmachemie Engineering and Consultants Private Limited
Data last updated:
Pharmachemie Engineering and Consultants Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the engineering sector. It was incorporated on 04 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U29100MH2020PTC338573. Its GSTIN is 27AALCP0901D1ZS (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Devendra Babu Naidu and Jony.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 1001 Plot No D – 1 Centrum Business Square, Thane, Maharashtra, India – 400604.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.38 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹68.36 Lakh (net margin 4.2%) and EBITDA of ₹1.06 Cr (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 210% over three years.
The company has about 4 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.11 Cr and satisfied charges of ₹20 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in December 2022.
For more details, the company can be reached via its website pharmachemengg.com.
Company details
Contact details
Pharmachemie Engineering and Consultants Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 1001 Plot No D – 1 Centrum Business Square, Thane, Maharashtra, India – 400604
- IndustryEngineering, Engineering, Procurement & Construction (EPC)
To see the full contact details of Pharmachemie Engineering and Consultants Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pharmachemie Engineering and Consultants is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pharmachemie Engineering and Consultants Private Limited, buy the company report.
Financials of Pharmachemie Engineering and Consultants Private Limited
FY 2024 filings availablePharmachemie Engineering and Consultants Private Limited reported revenue of ₹16.38 Cr (up 707% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 210% over three years, including 707% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.06 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68.36 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmachemie Engineering and Consultants Private Limited, buy the company report.
Board of directors of Pharmachemie Engineering and Consultants Private Limited
Pharmachemie Engineering and Consultants has 2 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devendra Babu Naidu | Director | 11 Oct 2025 | 1 Years 1 Months | Current |
| Jony Also directs: Tan Ton & Co Private Limited | Director | 11 Oct 2025 | 1 Years 1 Months | Current |
Auditor
Pharmachemie Engineering and Consultants Private Limited is audited by V S C & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V S C & ASSOCIATES | FY 2023 | 141677W |
Shareholding
The shareholding of Pharmachemie Engineering and Consultants Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Pharmachemie Engineering and Consultants Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2024 | 100942122 | Others | ₹11.49 Lakh | Open | |
| 14 Feb 2024 | 100874237 | Others | ₹1 Cr | Open | |
| 17 Sep 2021 | 100487491 | Others | ₹20 Lakh | Satisfied |
To see the full charge records of Pharmachemie Engineering and Consultants Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Pharmachemie Engineering and Consultants Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in December 2022.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2021 | Rights issue | ₹4.9 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pharmachemie Engineering and Consultants Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Arbitration matter | Filed against the company by Ambit Finvest Private Limited | Pending |
To see the full case history of Pharmachemie Engineering and Consultants Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmachemie Engineering and Consultants Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pharmachemie Engineering and Consultants Private Limited has a workforce of 4 employees on its EPFO records as of Jan 2025, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2024-25 | 4 |
| FY 2023-24 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Pharmachemie Engineering and Consultants Private Limited, buy the company report.
GST
Pharmachemie Engineering and Consultants has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCP0901D1ZS | Maharashtra | Active | 15 Apr 2020 |
To see the full GST registrations and return filing status of Pharmachemie Engineering and Consultants Private Limited, buy the company report.
Recent activity
Pharmachemie Engineering and Consultants Private Limited has 28 board changes on record since 2020: 15 appointments and 13 cessations. The latest: Arko Pratim Choudhury ceased to be Director on 11 Oct 2025.
23 earlier events are in the company report.
Frequently asked questions
Pharmachemie Engineering and Consultants is an active private limited company based in Thane, Maharashtra, India. The company works in the engineering industry. It was incorporated on 04 March 2020 (6+ years old) and is registered under CIN U29100MH2020PTC338573.
Pharmachemie Engineering and Consultants has 2 current directors:
- Devendra Babu Naidu - Director
- Jony - Director
The latest financial statements of Pharmachemie Engineering and Consultants on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Pharmachemie Engineering and Consultants is 27AALCP0901D1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pharmachemie Engineering and Consultants is U29100MH2020PTC338573. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmachemie Engineering and Consultants has 1 court case on record: 1 filed against it. 1 is pending.
Pharmachemie Engineering and Consultants was incorporated on 04 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Pharmachemie Engineering and Consultants has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in December 2022.
Arko Pratim Choudhury ceased to be Director on 11 Oct 2025. Devendra Babu Naidu was appointed as Director on 11 Oct 2025. Jony was appointed as Director on 11 Oct 2025. Pharmachemie Engineering and Consultants has 28 board changes on record in total.
Pharmachemie Engineering and Consultants can be reached through the website pharmachemengg.com. Its registered office is in Thane, Maharashtra, India.

